AC Immune SA ACIU
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.24% | 22.83% | -21.35% | -21.35% | -17.67% |
| Total Depreciation and Amortization | 6.99% | 1.47% | 10.93% | 10.93% | 13.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,341.94% | -97.09% | 42.59% | 42.59% | 260.03% |
| Change in Net Operating Assets | -20.08% | -231.37% | 218.00% | 218.00% | -110.03% |
| Cash from Operations | 9.87% | -21.25% | 9.66% | 9.66% | -409.75% |
| Capital Expenditure | -84.69% | 83.97% | -12.29% | -12.29% | -292.88% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.02% | -12.00% | 679.30% | 679.30% | 188.64% |
| Cash from Investing | -22.32% | -10.94% | 759.57% | 759.57% | 177.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.78% | -1.18% | -0.79% | -0.79% | -47.95% |
| Issuance of Common Stock | -- | 33.33% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | 200.00% | -400.00% |
| Cash from Financing | -2.90% | -6.05% | -4.32% | -4.32% | -27.95% |
| Foreign Exchange rate Adjustments | -1,098.40% | 99.32% | -822.16% | -822.16% | -113.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -146.92% | -63.87% | 138.49% | 138.49% | -513.10% |